UBS, Takes

UBS Takes Aim at Swiss Regulator as $20 Billion Capital Bill Looms

25.04.2026 - 00:00:42 | boerse-global.de

UBS accuses Swiss regulators of misleading documents over new capital rules requiring $20B in equity, deepening post-Credit Suisse rift as stock falls 5% weekly.

UBS Takes Aim at Swiss Regulator as $20 Billion Capital Bill Looms - Foto: über boerse-global.de
UBS Takes Aim at Swiss Regulator as $20 Billion Capital Bill Looms - Foto: über boerse-global.de

The relationship between Switzerland’s largest bank and its government has taken an acrimonious turn. UBS has publicly accused the Swiss Federal Council of issuing misleading documents in connection with new capital adequacy rules that could cost the lender roughly $20 billion in additional core equity. The bank’s management is now combing through every regulatory statement and official paper, signaling a deepening rift over the post-Credit Suisse regulatory overhaul.

Finance Minister Karin Keller-Sutter has framed the reforms as a necessary fix to a dangerous gap in the system. The core requirement: UBS must fully back its foreign subsidiaries with equity held at the parent company. It was precisely this missing safety net that doomed Credit Suisse, whose troubled overseas units could not be offloaded without crippling losses when crisis struck. The final capital adequacy ordinance, detailed by the Federal Council on Wednesday, also mandates full equity coverage for international operations.

JPMorgan analyst Kian Abouhossein remains unfazed by the political noise. On April 23, he reaffirmed his “Buy” rating on UBS shares with a price target of 43 CHF, pointing to the ongoing Credit Suisse integration and strong performance in global wealth management. The market, however, took a dimmer view. The stock shed roughly 3 percent on Thursday following the regulatory announcement, compared to a 1.2 percent decline in the broader European banking sector. The shares now trade just above their 200-day moving average, about 14 percent below the January high. On a weekly basis, the decline has reached around 5 percent, with the stock hovering near 35.17 euros and down more than 12 percent year-to-date.

Concessions Won, But No Relief in Sight

CEO Sergio Ermotti’s team did secure some compromises. Software assets and deferred tax claims will not be immediately deducted from core capital; instead, they can be amortized gradually over three years. JPMorgan views this as averted disaster — the worst-case scenario has been sidestepped. Yet the reprieve offers little comfort. The return on equity remains under pressure, and the bank’s effective minimum capital ratio would climb above 18 percent once all new rules are factored in, pushing the total capital requirement to roughly $22 billion.

Should investors sell immediately? Or is it worth buying UBS?

The government insists the package enjoys unified support. Keller-Sutter has emphasized that the reforms represent a collective decision. But UBS is having none of it. Management has branded the plans extreme and criticized what it sees as a unilateral Swiss approach that goes well beyond Basel III standards. Neither the United States nor the European Union demands full backing of foreign subsidiaries — a point the bank has hammered home repeatedly.

Political Battle and Economic Fallout

The fight is now moving to parliament, where debate on the banking law begins this summer. The legislative process could stretch up to a year, and a national referendum remains a possibility. Business lobby group Economiesuisse has warned that higher credit costs for domestic companies are inevitable. A study commissioned by UBS itself predicts a lasting drag on economic output if the rules stand as written.

Investor anxiety centers on one immediate question: will the stricter capital regime derail future share buybacks? The answer may come as soon as Wednesday, when UBS releases its quarterly results. Management will need to explain how the new capital demands fit into the bank’s financial planning. For now, UBS is sticking to its internal targets — a return on equity of roughly 15 percent by the end of 2026 and continued capital returns to shareholders. Since the new rules won’t take effect until 2027 at the earliest, the bank has a window to adapt.

UBS at a turning point? This analysis reveals what investors need to know now.

The coming months will test whether Ermotti can navigate this regulatory minefield without sacrificing the strategic gains made since the Credit Suisse rescue. For a bank that has spent the past year proving its resilience, the biggest challenge may still lie ahead.

Ad

UBS Stock: New Analysis - 25 April

Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated UBS analysis...

So schätzen die Börsenprofis UBS Aktien ein!

<b>So schätzen die Börsenprofis  UBS Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | CH0244767585 | UBS | boerse | 69241250 |